PLSE Q3 2025 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q3 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$86,000

Gross Profit

-$193,000-224.4% margin

Operating Income

-$20M-23682.6% margin

Net Income

-$19M-22540.7% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$109M

Total Liabilities

$16M

Stockholders' Equity

$93M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86,000	$0	—
Gross Profit	-$193,000	$0	—
Operating Income	-$20M	-$14M	-49.2%
Net Income	-$19M	-$13M	-52.9%

Revenue Segments

Operating Segments

$172,000100%